BACKGROUND: Elevated plasma levels of Lp(a) [lipoprotein(a)] are a causal risk factor for coronary heart disease and stroke ...

Twin studies predict a 50% spike in heart disease deaths in the next 5 years due to tobacco and marijuana use, with cannabis ...

Consumption of tobacco and marijuana is expected to spike heart disease death by 50pc in the next 5 years, according to twin ...

New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, ...

No-touch' vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA) has given final ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor tablets, 90 mg, aimed at preventing heart attack ...

Alembic Pharmaceuticals receives FDA approval for Ticagrelor Tablets 60 mg and 90 mg, therapeutically equivalent to Brilinta.